← Leaderboards
Ivan Pedrosa
Ut Southwestern Medical Center
$7,238,451
Attributed
$11,130,773
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,130,773 · 6
By mechanism
R01$6,363,818 · 2
U01$3,147,162 · 1
P50$1,378,978 · 2
T32$240,815 · 1
Top collaborators
- Ananth J Madhuranthakam6 shared
- Joseph A Maldjian6 shared
- Elena Vinogradov5 shared
- Ivan E Dimitrov4 shared
- Jochen Keupp4 shared
- Robert F Mattrey2 shared
- Takeshi Yokoo2 shared
- Yin Xi1 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Ananth J Madhuranthakam$2,882,549
- Jochen Keupp$426,080
- Albert Amos Montillo$1,033,200
- Yin Xi$165,769
Others in their field
Top investigators on “Renal Cell Carcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$23,387,256
- John H Sampson · Duke University$18,327,278
- William G Kaelin · Dana-Farber Cancer Institute$17,234,468
- M. Celeste Simon · University Of Pennsylvania$15,181,976
- Louis M Weiner · Fox Chase Cancer Center$9,813,757
- Othon Iliopoulos · Dana-Farber Cancer Institute$9,306,791
Research focus
Renal Cell CarcinomaMagnetic Resonance ImagingImageImaging ModalityProtocols DocumentationTumorTissuesIn VivoMedical CenterRenal CarcinomaCollaborationsBaseMeasurementPerfusionBlood VesselsPhysiologicalClinical PracticeAngiogenesisMetabolicEvaluationHeterogeneitySpecimenImaging TechniquesMonitor
Grant awards (33)
Chemical Exchange Saturation Transfer (CEST) MRI for the Characterization Small Renal Masses$379,324
R01 · FY2025 · CA
Core D: Translational Imaging Core$259,666
P50 · FY2025 · CA · contact PI
Training Clinician Scientists as Outstanding Clinicians and Imaging Scientists$1
T32 · FY2025 · EB
Chemical Exchange Saturation Transfer (CEST) MRI for the Characterization Small Renal Masses$380,460
R01 · FY2024 · CA
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA$331,538
R01 · FY2024 · CA · contact PI
Training Clinician Scientists as Outstanding Clinicians and Imaging Scientists$240,814
T32 · FY2024 · EB
Core D: Translational Imaging Core$128,635
P50 · FY2024 · CA · contact PI
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA$471,752
R01 · FY2023 · CA · contact PI
Chemical Exchange Saturation Transfer (CEST) MRI for the Characterization Small Renal Masses$462,317
R01 · FY2023 · CA
Core D: Translational Imaging Core$120,845
P50 · FY2023 · CA · contact PI
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA$640,054
R01 · FY2022 · CA · contact PI
Chemical Exchange Saturation Transfer (CEST) MRI for the Characterization Small Renal Masses$413,584
R01 · FY2022 · CA
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response$211,728
U01 · FY2022 · CA
Core D: Translational Imaging Core$129,289
P50 · FY2022 · CA · contact PI
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response$677,431
U01 · FY2021 · CA
Chemical Exchange Saturation Transfer (CEST) MRI for the Characterization Small Renal Masses$447,959
R01 · FY2021 · CA
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA$254,691
R01 · FY2021 · CA · contact PI
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response$694,766
U01 · FY2020 · CA
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA$577,621
R01 · FY2020 · CA · contact PI
Core D: Translational Imaging Core$153,147
P50 · FY2020 · CA · contact PI
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA$535,402
R01 · FY2019 · CA · contact PI
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response$229,609
U01 · FY2019 · CA
Core D: Translational Imaging Core$141,055
P50 · FY2019 · CA · contact PI
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response$662,444
U01 · FY2018 · CA
Core D: Translational Imaging Core$151,829
P50 · FY2018 · CA · contact PI
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response$671,184
U01 · FY2017 · CA
Core D: Translational Imaging Core$151,829
P50 · FY2017 · CA · contact PI
Core D: Translational Imaging Core$142,683
P50 · FY2016 · CA · contact PI
Non-invasive Physiologic Predictors of Aggressiveness in Renal Cell Carcinoma$293,871
R01 · FY2015 · CA · contact PI
Non-invasive Physiologic Predictors of Aggressiveness in Renal Cell Carcinoma$286,247
R01 · FY2014 · CA · contact PI
Non-invasive Physiologic Predictors of Aggressiveness in Renal Cell Carcinoma$278,574
R01 · FY2013 · CA · contact PI
Non-invasive Physiologic Predictors of Aggressiveness in Renal Cell Carcinoma$297,635
R01 · FY2012 · CA · contact PI
Non-invasive Physiologic Predictors of Aggressiveness in Renal Cell Carcinoma$312,789
R01 · FY2011 · CA · contact PI